全球耳管设备市场 - 2023-2030
市场调查报告书
商品编码
1373398

全球耳管设备市场 - 2023-2030

Global Ear Tube Devices Market - 2023-2030

出版日期: | 出版商: DataM Intelligence | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

耳管装置,也称为鼓膜造口管或通气管,是一种小型、通常为圆柱形的植入物,用于治疗慢性渗出性中耳炎(中耳积液)或復发性耳部感染等疾病。这些管子透过小型外科手术插入耳膜,形成一个临时通道,平衡压力并从中耳排出液体。它们的主要目的是缓解症状、改善听力和预防復发感染。

耳管通常由不同的材料组成,例如硅胶、塑胶或金属,根据其生物相容性和耐用性进行选择。它们透过改善个人(尤其是儿童)的耳朵健康和整体生活质量,在治疗持续性耳朵问题方面发挥着至关重要的作用。

市场动态:驱动因素与限制因素

创新的耳管设计使用液体注入材料来增强耳部感染的治疗效果,预计将推动市场成长

2023年,来自哈佛大学维斯仿生工程研究所、哈佛大学约翰·A·保尔森工程与应用科学学院以及波士顿马萨诸塞州眼耳科的一组研究人员合作创造了一种革命性的新型耳管装置,名为「鼓膜造口管」(TT)。这些管子采用液体注入材料,具有独特的弯曲管腔形状,可增强药物输送和液体引流并防止细菌黏附。

随着创新 iTT「鼓膜造口管」(TT) 的推出,耳管设备市场预计将出现成长,这种创新 iTT 具有增强的功能和在人类患者中进行临床试验的潜力。这些 iTT 在解决传统 TT 的局限性方面取得了重大进展,使其成为寻求改善耳部感染(尤其是儿童)治疗方案的医疗保健提供者和家长的首选治疗方案。该技术在其他植入式医疗导管(例如大脑和胆管分流器)的设计方法上具有多功能性,可扩大市场范围并吸引更广泛的医疗专业人员和患者。

因此,这项创新有可能为中耳疾病患者提供更安全、更有效率、可客製化的解决方案,从而彻底改变耳管设备市场。这将推动医疗保健产业的需求和投资。

此外,老年人口的不断增长、人们对耳管益处的认识不断提高、耳部感染髮生率的增加以及对微创手术的需求不断增加,预计将在预测期内推动市场发展。

克制:

患者和医疗保健专业人员对耳管装置的好处缺乏认识,有些患者或医生可能更喜欢药物治疗或观察等待等替代疗法。此外,对与耳管插入相关的潜在併发症或副作用的担忧可能进一步促成这种偏好。由于这些因素,耳管设备市场预计将在预测期内受到阻碍。

目录

第 1 章:方法与范围

  • 研究方法论
  • 报告的研究目的和范围

第 2 章:定义与概述

第 3 章:执行摘要

  • 按材料分类的片段
  • 按指示显示的片段
  • 最终使用者的片段
  • 按地区分類的片段

第 4 章:动力学

  • 影响因素
    • 司机
      • 使用液体注入材料的创新耳管设计
    • 限制
      • 与耳管插入相关的併发症或副作用
    • 机会
    • 影响分析

第 5 章:产业分析

  • 波特五力分析
  • 供应链分析
  • 定价分析
  • 监管分析
  • 管道分析
  • 专利分析
  • DMI 意见

第 6 章:COVID-19 分析

  • COVID-19 分析
    • 新冠疫情爆发前的情景
    • 新冠疫情期间的情景
    • 新冠疫情后的情景
  • COVID-19 期间的定价动态
  • 供需谱
  • 疫情期间政府与市场相关的倡议
  • 製造商策略倡议
  • 结论

第 7 章:按材料

  • 硅胶管
  • 氟塑胶管
  • 金属管
  • 其他的

第 8 章:依指示

  • 中耳炎
    • 其他的
  • 耳咽管功能障碍
  • 其他的

第 9 章:最终用户

  • 医院
  • 耳鼻喉科诊所
  • 门诊手术中心
  • 其他的

第 10 章:按地区

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 亚太其他地区
  • 中东和非洲

第 11 章:竞争格局

  • 竞争场景
  • 市场定位/份额分析
  • 併购分析

第 12 章:公司简介

  • Anthony Products, Inc.
    • 公司简介
    • 产品组合和描述
    • 财务概览
    • 主要进展
  • Olympus America
  • Adept Medical
  • Atos Medical AB
  • Summit Medical LLC
  • Medtronic
  • Smith+Nephew
  • Heinz Kurz GmbH Medizintechnik
  • Hummingbird TTS Preceptis Medical
  • Invotec International Inc.

第 13 章:附录

简介目录
Product Code: MD7168

Overview

Ear tube devices, also known as tympanostomy tubes or ventilation tubes, are small, typically cylindrical implants used to treat conditions like chronic otitis media with effusion (fluid buildup in the middle ear) or recurrent ear infections. These tubes are inserted into the eardrum through a minor surgical procedure, creating a temporary passage that equalizes pressure and drains fluid from the middle ear. Their primary purpose is to alleviate symptoms, improve hearing, and prevent recurring infections.

Ear tubes are typically composed of different materials such as silicone, plastic, or metal, selected for their biocompatibility and durability. They play a vital role in treating persistent ear problems in individuals, especially children, by improving their ear health and overall quality of life.

Market Dynamics: Drivers and Restraints

Innovative ear tube design uses liquid-infused materials to enhance treatment results for ear infections is expected to drive market growth

In 2023, a team of researchers from the Wyss Institute for Biologically Inspired Engineering at Harvard University, Harvard John A. Paulson School of Engineering and Applied Sciences, and Massachusetts Eye and Ear in Boston collaborated to create a revolutionary new type of ear tube device called "tympanostomy tubes" (TTs). These tubes use a liquid-infused material and have a unique curved lumen shape that enhances drug delivery, and fluid drainage and prevents bacterial adhesion.

The ear tube devices market is expected to experience growth with the introduction of innovative iTTs "tympanostomy tubes" (TTs) that possess enhanced functionality and potential for clinical trials in human patients. These iTTs provide a significant advancement in addressing the limitations of conventional TTs, making them a preferred treatment option for healthcare providers and parents seeking improved treatment options for ear infections, especially in children. This technology's versatility in design approach for other implantable medical conduits, such as shunts for the brain and bile ducts, could expand the market's scope and appeal to a broader range of medical professionals and patients.

Therefore, this innovation has the potential to revolutionize the market for ear tube devices by providing safer, more efficient, and customizable solutions for patients with middle ear conditions. This will drive demand and investment in the healthcare sector.

Furthermore, the growing geriatric population, rising awareness about the benefits of ear tubes, increasing incidence of ear infections, and increasing demand for minimally invasive procedures are the factors expected to drive the market over the forecast period.

Restraint:

Lack of awareness among patients and healthcare professionals about the benefits of ear tube devices, and alternative treatments, such as medication or watchful waiting, may be preferred by some patients or physicians. Additionally, concerns about potential complications or side effects associated with ear tube insertion may further contribute to this preference. As a result of these factors, the market for ear tube devices is expected to hamper over the forecast period.

Segment Analysis

The global ear tube devices market is segmented based on material, indication, end user, and region.

The silicone tubes from the material segment accounted for approximately 36.6% of the ear tube devices market share

Silicone tubes are frequently used in ear tubes, also known as tympanostomy tubes or grommets. Their inherent softness, flexibility, and biocompatibility make them ideal for situations where patient comfort and compatibility with delicate bodily tissues are crucial. These qualities are highly valued in pediatric ear tube surgeries, where the gentle nature of silicone tubes helps to minimize the risk of tissue damage during insertion.

Additionally, they provide a comfortable and dependable solution for treating conditions like chronic ear infections and middle ear ventilation issues in young patients, ensuring their well-being throughout the treatment process. Furthermore, the increasing prevalence of ear disorders, growth in the number of children with ear issues, advantages of silicone tubes, and awareness about the benefits of ear tubes are the factors expected to drive the market over the forecast period.

For instance, the World Health Organization (WHO) has reported that there are currently 1.5 billion people around the world living with some level of hearing impairment. Out of this number, 430 million are facing disabling hearing loss. It is projected that by the year 2050, this number will rise to more than 700 million. Notably, over a quarter of individuals aged 60 and above grapple with disabling hearing loss, and approximately 30% of this age group suffer from some form of hearing impairment.

Also, globally, 34 million children are affected by deafness or hearing loss, with a concerning 60% of these cases stemming from preventable causes. This highlights the urgent need for hearing-related interventions, such as ear tube devices, to address hearing problems across different age groups and demographics. This is especially important for pediatric populations.

Moreover, Collar Button Ear Tubes represent a distinct category of silicone ear tubes known for their exceptional softness, flexibility, and elasticity. They are incredibly flexible and can be easily manipulated and compressed, which makes the process of insertion and removal simpler. This exceptional design feature makes Collar Button Ear Tubes a preferred choice for healthcare professionals who are looking to address ear-related conditions, as they provide a more user-friendly and efficient solution for patients requiring ear tube placement. Hence, owing to the above factors, the market segment is expected to hold the largest market share over the forecast period.

Geographical Analysis

North America accounted for approximately 40.7% of the market share in 2022

North America is expected to hold the largest market share owing to the FDA approvals of ear tube devices, the increasing prevalence of ear disorders, and the development of novel ear tube devices by research institutes.

For instance, on August 15, 2022, Preceptis Inc. was granted an expanded clearance by the U.S. FDA for its Hummingbird Tympanostomy Tube System, allowing for office-based pediatric ear tube procedures in all children six months and older. The device was previously cleared for children aged 6-24 months. The minimally invasive device is designed to create an incision in the ear canal, enabling the delivery of the ear tube in a single pass without requiring general anesthesia.

Additionally, in 2023, a new ear tube was developed by Harvard researchers to enhance treatment outcomes for patients with ear infections. The tube is made up of liquid-infused materials and optimized geometry to prevent blockages and improve performance. The design was created using a screening algorithm and has fluid transport properties. This innovative design is anticipated to decrease the number of visits for children suffering from chronic ear infections and improve results for patients with ear-related ailments. Thus, owing to the above factors, the North America region is expected to hold the largest market share over the forecast period.

COVID-19 Impact Analysis:

COVID-19 had a significant impact on the ear tube devices market. Otolaryngologists, along with their staff, are at a higher risk of contracting COVID-19 due to their direct exposure to mucus and aerosolized particles during procedures and examinations in the head and neck area. Reports from countries like China, Italy, Iran, and the United Kingdom indicate that otolaryngologists are among the most vulnerable to contracting the SARS-CoV-2 virus, especially if they are not wearing appropriate personal protective equipment (PPE).

Moreover, according to the National Center for Biotechnology Information, 2022, the incidence of otitis media was drastically reduced, the incidence of complications of otitis media was reduced, and the number of patients visiting the emergency room due to otitis media decreased.

Additionally, due to the COVID-19 pandemic, there has been a significant decrease in the rate of pediatric tympanostomy tube placement. The age of patients undergoing surgery has increased and more children are receiving care in a tertiary setting. These findings may indicate changes in the prevalence of acute and chronic otitis media caused by the pandemic.

Therefore, the COVID-19 pandemic impacted the use of ear tube devices by decreasing the number of tympanostomy tube placements, increasing the risk of infection, decreasing middle ear effusion, generating aerosols during myringotomy, and causing ear pressure.

Competitive Landscape

The major global players in the ear tube devices market include: Anthony Products, Inc., Olympus America, Adept Medical, Atos Medical AB, Summit Medical LLC, Medtronic, Smith+Nephew, Heinz Kurz GmbH Medizintechnik, Hummingbird TTS Preceptis Medical, and Invotec International Inc. among others.

Key Developments

  • On August 15, 2022, Preceptis Medical, Inc. is a surgical technology company that focuses on providing less invasive options for pediatric patients. The Hummingbird Tympanostomy Tube System (TTS) received clearance from the U.S. FDA for expanded indications for use in office-based pediatric ear tube procedures. This new labeling now allows in-office procedures for all children six months and older, whereas it was previously only cleared for children aged 6-24 months.
  • On June 2, 2021, Preceptis Medical launched its Hummingbird tympanostomy tube system for office-based pediatric ear tube procedures.
  • On January 24, 2020, Smith & Nephew acquired Tusker Medical for an undisclosed sum. Tusker Medical is the developer of the Tula System, an in-office ear tube delivery system used to treat recurrent or persistent ear infections. The pediatric ear tubes received FDA breakthrough device designation in November 2019.

Why Purchase the Report?

  • To visualize the global ear tube devices market segmentation based on material, indication, end user, and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of ear tube devices market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global ear tube devices market report would provide approximately 61 tables, 59 figures, and 186 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Material
  • 3.2. Snippet by Indication
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Innovative ear tube design using liquid-infused materials
    • 4.1.2. Restraints
      • 4.1.2.1. Complications or side effects associated with ear tube insertion
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Pipeline Analysis
  • 5.6. Patent Analysis
  • 5.7. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Material

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 7.1.2. Market Attractiveness Index, By Material
  • 7.2. Silicone Tubes*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Fluoroplastic Tubes
  • 7.4. Metal Tubes
  • 7.5. Others

8. By Indication

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
    • 8.1.2. Market Attractiveness Index, By Indication
  • 8.2. Otitis Media*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
      • 8.2.2.1. Others
  • 8.3. Eustachian Tube Dysfunction
  • 8.4. Others

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. ENT Clinics
  • 9.4. Ambulatory Surgical Centers
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. UK
      • 10.3.6.3. France
      • 10.3.6.4. Spain
      • 10.3.6.5. Italy
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Anthony Products, Inc.*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Olympus America
  • 12.3. Adept Medical
  • 12.4. Atos Medical AB
  • 12.5. Summit Medical LLC
  • 12.6. Medtronic
  • 12.7. Smith+Nephew
  • 12.8. Heinz Kurz GmbH Medizintechnik
  • 12.9. Hummingbird TTS Preceptis Medical
  • 12.10. Invotec International Inc.

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us